D
Summit Therapeutics Inc. SMMT
$26.20 $0.190.73% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 360.42M 15.59M 14.44M 20.39M 13.81M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -205.00K 264.00K --
Total Operating Expenses 568.44M 66.85M 65.61M 58.38M 44.61M
Operating Income -568.44M -66.85M -65.61M -58.38M -44.61M
Income Before Tax -565.71M -62.91M -61.20M -56.25M -60.39M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -565.71M -62.91M -61.20M -56.25M -60.39M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -565.71M -62.91M -61.20M -56.25M -60.39M
EBIT -568.44M -66.85M -65.61M -58.38M -44.61M
EBITDA -568.40M -66.83M -65.59M -58.36M -44.59M
EPS Basic -0.76 -0.09 -0.08 -0.08 -0.09
Normalized Basic EPS -0.48 -0.05 -0.05 -0.05 -0.04
EPS Diluted -0.76 -0.09 -0.09 -0.08 -0.09
Normalized Diluted EPS -0.48 -0.05 -0.05 -0.05 -0.04
Average Basic Shares Outstanding 742.62M 738.08M 737.50M 726.66M 707.90M
Average Diluted Shares Outstanding 742.62M 738.08M 737.50M 726.66M 707.90M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --